Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients

被引：0
作者：
Asieh Mansour
Mohammad Reza Mohajeri-Tehrani
Majid Samadi
Hadis Gerami
Mostafa Qorbani
Nick Bellissimo
Hossein Poustchi
Azita Hekmatdoost
机构：
[1] Shahid Beheshti University of Medical Sciences,Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute
[2] Tehran University of Medical Sciences,Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute
[3] Tehran University of Medical Sciences,Radiology Department, Shariati Hospital
[4] Tehran University of Medical Sciences,Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular
[5] Alborz University of Medical Sciences,Cellular Sciences Institute
[6] Tehran University of Medical Sciences,Non
[7] Ryerson University,communicable Diseases Research Center
[8] Tehran University of Medical Sciences,Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Endocrinology and Metabolism Research Institute
来源：
Acta Diabetologica | 2019年 / 56卷
关键词：
Hepatic fibrosis; Type 2 diabetes; NAFLD; Risk factors; Liver enzymes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1199 / 1207
页数：8
相关论文
共 175 条
  • [1] Bril F(2017)Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action Diabetes Care 40 419-430
  • [2] Cusi K(2016)Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome Intern Emerg Med 11 3-10
  • [3] Miele L(2018)Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis Diabetes Care 41 372-382
  • [4] Gasbarrini G(2016)Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis J Gastroenterol Hepatol 31 936-944
  • [5] Giorgio V(2011)Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity Ann Med 43 617-649
  • [6] Gasbarrini A(2018)Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes J Hepatol 68 147-156
  • [7] Grieco A(2013)Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population Am J Gastroenterol 108 1861-437
  • [8] Mantovani A(2017)Non-alcoholic fatty liver disease: the emerging burden in cardiometabolic and renal diseases Diabetes Metab J 41 430-1123
  • [9] Byrne CD(2000)Liver fibrosis in overweight patients Gastroenterology 118 1117-1396
  • [10] Bonora E(2017)Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: an age-dependent risk profiling study Liver Int 37 1389-178
12345678910